These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10588764)

  • 1. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.
    Salinas R; Counsell C; Prasad K; Gelband H; Garner P
    Trop Med Int Health; 1999 Nov; 4(11):713-8. PubMed ID: 10588764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintics for people with neurocysticercosis.
    Monk EJM; Abba K; Ranganathan LN
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2000; (2):CD000215. PubMed ID: 10796510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain).
    Salinas R; Prasad K
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000215. PubMed ID: 17636621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
    Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
    Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA;
    Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
    Matthaiou DK; Panos G; Adamidi ES; Falagas ME
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids for neurocysticercosis: a systematic review and meta-analysis of randomized controlled trials.
    Cuello-García CA; Roldán-Benítez YM; Pérez-Gaxiola G; Villarreal-Careaga J
    Int J Infect Dis; 2013 Aug; 17(8):e583-92. PubMed ID: 23339852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for treating urinary schistosomiasis.
    Danso-Appiah A; Utzinger J; Liu J; Olliaro P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000053. PubMed ID: 18646057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.